Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Simonetta BandieraSophie PernotHussein El SaghireSarah C DurandChristine ThumannEmilie CrouchetTao YeIsabel FofanaMarine A OudotJochen BarthsCatherine SchusterPatrick PessauxMarkus H HeimThomas F BaumertMirjam B ZeiselPublished in: Journal of virology (2016)
HCV is a leading cause of chronic liver disease and cancer. However, how HCV induces liver cancer remains poorly understood. There is accumulating evidence that a viral cure does not eliminate the risk for HCC development. Thus, there is an unmet medical need to develop novel approaches to predict and prevent virus-induced HCC. miRNA expression is known to be deregulated in liver disease and cancer. Furthermore, miRNAs are essential for HCV replication, and HCV infection alters miRNA expression. However, how miRNAs contribute to HCV-driven pathogenesis remains elusive. Here we show that HCV induces miRNAs that may contribute to liver injury and carcinogenesis. The miR-146a-5p level was consistently increased in different cell-based models of HCV infection and in HCV patient-derived liver tissue. Furthermore, miR-146a-5p increased HCV infection. Collectively, our data are relevant to understanding viral pathogenesis and may open perspectives for novel biomarkers and prevention of virus-induced liver disease and HCC.
Keyphrases
- hepatitis c virus
- human immunodeficiency virus
- liver injury
- drug induced
- poor prognosis
- high glucose
- diabetic rats
- sars cov
- healthcare
- oxidative stress
- cell proliferation
- stem cells
- young adults
- single cell
- bone marrow
- long non coding rna
- endothelial cells
- cell therapy
- mesenchymal stem cells
- deep learning
- lymph node metastasis